The effect of renal cation transport inhibitors on the in vivo and in vitro accumulation and efflux of cephaloridine.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002509:Cephaloridine / Q000378:metabolism*; D004396:Coloring Agents / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D010880:Piperidines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D011806:Quinolinium Compounds / Q000494:pharmacology*; D011817:Rabbits; D013757:Tetraethylammonium Compounds / Q000378:metabolism; D010130:p-Aminohippuric Acid / Q000378:metabolism
D004396:Coloring Agents; D010880:Piperidines; D011743:Pyrimidines; D011806:Quinolinium Compounds; D013757:Tetraethylammonium Compounds; C016855:cyanine 863; C010482:mepiperphenidol; D002509:Cephaloridine; D010130:p-Aminohippuric Acid